AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04884087 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Ecological Momentary Assessment (EMA; Metricwire) Prompts 6x/day
Description: Participants receive 6 EMA survey prompts daily for the duration of the study.
Study NCT04884087 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Incentive Structure - fixed
Description: Those assigned to the fixed incentive condition will earn a fixed bonus based on EMA completion (50-74%=$3; 75-89%=$5; ≥90%=$10) each week.
Study NCT04884087 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Incentive Structure - prize based
Description: Those assigned to the prize-based incentive will be rewarded for high survey completion with increasing numbers of draws depending on their level of response to EMA prompts each week (50-74%=1 draw, 75-89%=2 draws, ≥90%=3 draws). For each draw, individuals will use the EMA app to spin the wheel to see which prize amount they earn. Out of a total of 500 total draws, 50% will be $1, 43.6% will be $3, 6% will be medium prizes ($5), and 0.4% will be a jumbo prize ($90).
Study NCT04704323 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CAP-100
Description: CAP-100 (humanized antibody against C-C-chemokine receptor 7 \[CCR\]7)
Study NCT06561568 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physical therapy
Description: Conventional physical therapy protocol for chondromalacia patellae consist of stretches to warm up and cool down Resistance training ,in which patient will perform each exercise for 3 sets of 10 repetitions. Each repetition will be given with a 10 second hold.
Study NCT06561568 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy
Description: Conventional physical therapy protocol for chondromalacia patellae consist of stretches to warm up and cool down Resistance training ,in which patient will perform each exercise for 3 sets of 10 repetitions. Each repetition will be given with a 10 second hold.
Study NCT06561568 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiotaping
Description: Kinesio tape will be applied on Vastus medialis Oblique and around the patella.~• Frequency: 3 times a week for 4 weeks.
Study NCT05600010 — intervention group
Intervention type: OTHER
Intervention: Microplastics
Description: Detection of microplastics as a yes/no value
Study NCT06445855 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interpersonal relationship-based intervention program
Description: An interpersonal relations-based intervention program will be implemented with an online intervention platform.
Study NCT06445855 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Interpersonal relationship-based intervention program
Description: An interpersonal relations-based intervention program will be implemented with an online intervention platform.
Study NCT05120232 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Unified Protocol
Description: A transdiagnostic, cognitive behavioral therapy.
Study NCT05120232 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Modified Unified Protocol (UP+)
Description: A transdiagnostic, cognitive behavioral therapy.
Study NCT04692688 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: APX3330
Description: APX3330, a small-molecule oral tablet, is a Ref-1 inhibitor that can potentially reduce proinflammatory and hypoxic signaling that contributes to several eye diseases.
Study NCT04692688 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablets are identical to APX3330 tablets except for the absence of the active pharmaceutical ingredient.
Study NCT05905718 — intervention group
Intervention type: OTHER
Intervention: assessment
Description: Assessments of thoracic kyphosis angle, balance performance, and gait performance.
Study NCT06468579 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GT20029
Description: Stage 1: GT20029 gel single ascending dose (1mg, 2mg, 5mg, 10mg) with 14 days washout window; Multi ascending dose (2mg QD, 2mg Q12h, 5mg QD, 5mg Q12h,10mg QD) for 14 consecutive days; Stage 2: GT20029 solution multi ascending dose (5mg QD, 10mg QD, 20mg QD) for 14 consecutive days;
Study NCT06468579 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: GT20029 matching placebo
Description: Stage 1: GT20029 gel matching placebo single ascending dose (1mg, 2mg, 5mg, 10mg) with 14 days washout window; Multi ascending dose (2mg QD, 2mg Q12h, 5mg QD, 5mg Q12h,10mg QD) for 14 consecutive days; Stage 2: GT20029 solution matching placebo multi ascending dose (5mg QD, 10mg QD, 20mg QD) for 14 consecutive days;
Study NCT04716309 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Open reduction and volar locking plate and closed reduction and K-wires.
Description: DVR Anatomic Plate, K-wires
Study NCT06236217 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Carotid Ultrasound
Description: The carotid artery corrected flow time (FTc) was used in patients to optimize the volume status before performing spinal anesthesia.
Study NCT06236217 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electrical cardiometry
Description: Stroke volume variation (SVV) measured by electrical cardiometry (EC) was used to optimize the volume status before performing spinal anesthesia.
Study NCT06380140 — intervention group
Intervention type: PROCEDURE
Intervention: Open Tension-free Inguinal Hernia Repair
Description: A blood sample is taken the day after surgery
Study NCT06508983 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SG301 Injection
Description: Dosage form: solution for infusion Route of administration: intravenous Frequency: weekly intervals (QW) for 8 weeks, then every 2 weeks (Q2W) thereafter.
Study NCT06508983 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: SG301 placebo
Description: Dosage form: solution for infusion Route of administration: intravenous Frequency: weekly intervals (QW) for 8 weeks, then every 2 weeks (Q2W) thereafter.
Study NCT06508983 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: pomalidomide
Description: Dosage form: capsule Route of administration: oral Dosage: 4 mg Frequency: once daily on Days 1 through 21 of each 28-day cycle.
Study NCT05444673 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paprizumab combined with cisplatin and 5-FU
Description: Patients with advanced temporal bone cancer were treated with pabulizumab combined with cisplatin and 5-FU
Study NCT06508983 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pomalidomide
Description: Dosage form: capsule Route of administration: oral Dosage: 4 mg Frequency: once daily on Days 1 through 21 of each 28-day cycle.
Study NCT06508983 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: dexamethasone
Description: Dosage form: tablets or solution for infusion Route of administration: oral or intravenous Dosage: 40 mg (participants with BMI \< 18.5 kg/m2 received 20 mg dexamethasone) Frequency: once daily on Day 1, 8, 15, 22 of each 28-day treatment cycle.
Study NCT06508983 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dexamethasone
Description: Dosage form: tablets or solution for infusion Route of administration: oral or intravenous Dosage: 40 mg (participants with BMI \< 18.5 kg/m2 received 20 mg dexamethasone) Frequency: once daily on Day 1, 8, 15, 22 of each 28-day treatment cycle.
Study NCT05570422 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KRC-01
Description: KRC-01 is a solution that contains hydrogen peroxide 3% with sodium hyaluronate 1%. Hydrogen peroxide is the active ingredient for this radiosensitizer.
Study NCT05570422 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: External Beam Radiation Therapy
Description: * Target definition for EBRT will be based on 3D imaging by computed tomography, positron emission tomography with computed tomography, or MRI.~* Intensity-modulated radiotherapy (IMRT) must be used.~* IMRT should be given once daily Monday-Friday, 5 fractions per week.
Study NCT05570422 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cisplatin
Description: * Weekly concomitant cisplatin (40 mg/m2) during EBRT~* Neo-adjuvant chemotherapy or other forms of antineoplastic treatment apart from weekly concomitant cisplatin (40 mg/m2) are not allowed.~* Adjuvant chemotherapy (after completion of EBRT+BT) is not allowed.
Study NCT05570422 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: brachytherapy
Description: * BT treatment planning will be based on 3D-image-guided BT by MRI.~* Low-dose-rate, pulsed-dose-rate, or high-dose-rate BT
Study NCT05875480 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: synchronized telerehabilitation
Description: In the synchronized telerehabilitation group, the exercise program of the first 2 weeks was submitted via Albert Health Assistant application and patients were asked to do these exercises regularly during this process. after 2 weeks, they were treated 2 days a week until the 6th week by meeting with the physiotherapist in real time via the Albert Health Assistant application. In the remaining days, they were asked to follow the exercise videos uploaded to the Albert system, it will be checked whether they have done the daily exercises, and a daily reminder message will be sent through the system.
Study NCT05875480 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: asynchronized telerehabilitation
Description: The exercise program for the asynchronized telerehabilitation group will be uploaded to the Albert Health Assistant in the form of 2-week programs in video form from the first Day. Whether the patients apply these videos on a daily basis will be checked through the system, a message reminding the daily routine exercise program will be sent through the system.
Study NCT05875480 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: supervised (face to face) rehabilitation
Description: In the supervised physiotherapy group, the exercise program of the first 2 weeks was submitted via Albert Health Assistant application and patients were asked to do these exercises regularly during this process. After 2 weeks, they attended the rehabilitation program in the physical therapy department of the hospital accompanied by a physiotherapist, starting from the 14th postoperative day, 2 days a week until the 6th week. The ROM, pain, functional and general health evaluations of the patients in this group were carried out on the online platform. In addition, on the days when they did not come to treatment, their daily routine exercises were followed through the Albert system.
Study NCT05769270 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer Navigation and Coping Skills
Description: Participants will receive 6 sessions of peer navigation and coping skills
Study NCT05769270 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treatment as Usual
Description: Participants will receive referrals for PrEP and services
Study NCT05769270 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Treatment as Usual
Description: Participants will receive referrals for PrEP and services
Study NCT05967286 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alpelisib
Description: Given PO
Study NCT05967286 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo biopsy
Study NCT05967286 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biopsy
Description: Undergo biopsy
Study NCT05967286 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood
Study NCT05967286 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo collection of blood
Study NCT05967286 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo bone scans
Study NCT05967286 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bone Scan
Description: Undergo bone scans
Study NCT05967286 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT
Study NCT05967286 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography
Description: Undergo CT
Study NCT05967286 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT05580289 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: half-shower and hot pack
Description: The patients in the experimental group will be given hot application and half shower applications and the pain levels of the patients and the development of bladder retention will be followed.
Study NCT05794529 — intervention group
Intervention type: OTHER
Intervention: There are no interventions in the present study
Description: There are no interventions in the present study
Study NCT05080829 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Myeloid mutations measurement
Description: Measure of myeloid mutations by NGS when detection of refractory or relapsed CML is done
Study NCT05619926 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STSP-0601 for Injection
Description: Intravenous Injection
Study NCT06319911 — intervention group
Intervention type: DEVICE
Intervention: AETOS
Description: The AETOS Shoulder System will be implanted into the right or left shoulder in the anatomic or reverse configuration
Study NCT05325164 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methadone
Description: Methadone
Study NCT05325164 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Morphine
Description: Morphine
Study NCT06482060 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Stabilization splint
Description: Stabilization splint application is a treatment that improves the function of TMJ and masticatory muscles by creating a balanced, stable occlusion to reduce the effects of occlusal interference and parafunctional habits and eliminate associated pain.
Study NCT06482060 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Stabilization splint
Description: Stabilization splint application is a treatment that improves the function of TMJ and masticatory muscles by creating a balanced, stable occlusion to reduce the effects of occlusal interference and parafunctional habits and eliminate associated pain.
Study NCT05967286 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT05967286 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olaparib
Description: Given PO
Study NCT05967286 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Olaparib
Description: Given PO
Study NCT05967286 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET
Study NCT05934981 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery under low pressure and warm and humidified CO2 Insufflation
Description: low pressure pneumoperitoneum (5-7mmHg) and use warm (35°C), humidified (95% relative humidity) CO2 insufflation.
Study NCT05934981 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic surgery under low pressure and conventional Insufflation
Description: low pressure pneumoperitoneum (5-7mmHg), and use standard room temperature with dry insufflation.
Study NCT05786573 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Obexelimab
Description: Obexelimab is a monoclonal antibody that simultaneously binds CD19 and FcγRIIb, resulting in down regulation of B cell activity.
Study NCT05786573 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05281861 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Zirconia reinforced Lithium disilicate (Vita Ambria) ceramic onlay restoration
Description: In experimental group, Participants will be restored with onlay ceramic restorations constructed from zirconia reinforced Lithium disilicate (Vita Ambria) glass ceramic
Study NCT05281861 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lithium disilicate (IPS e-max press) ceramic onlay restoration
Description: In control group, Participants will be restored with onlay ceramic restorations constructed from Lithium disilicate (IPS e-max press) glass ceramic
Study NCT05643911 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: HFNC
Description: In the HFNC group, patients will receive HFNC oxygen therapy for 20 minutes.
Study NCT05643911 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: NIV
Description: Patients will receive NIV for 20 minutes delivered with a naso-buccal or face mask according to the patient's tolerance.
Study NCT06368219 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ketamine- midazolam versus ketamine- propofol
Description: * Group A: 25 patients will receive ketamine (0.5 mg/kg) plus midazolam (0.05 mg/kg)~* Group B: 25 patients will receive ketamine (0.5 mg/kg) plus propofol (0.5 mg/kg)
Study NCT06389162 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: transcranial direct current stimulation
Description: Transcranial direct current stimulation is a type of non-invasive brain stimulation that involves passing a weak current between two electrodes placed on the scalp.
Study NCT06389162 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial direct current stimulation
Description: Transcranial direct current stimulation is a type of non-invasive brain stimulation that involves passing a weak current between two electrodes placed on the scalp.
Study NCT04937530 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RT001
Description: RT001 8.64 g/d (3 capsules TID) for 1 month followed by 5.76 g/d (3 capsules BID) for an additional 11 months
Study NCT04937530 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo Comparator: Placebo Inactive comparator capsule 960 mg/capsule: 3 capsules TID for 4 weeks, followed by 3 capsules BID for the remaining 44 weeks.
Study NCT05308693 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education material - Patient Compatible Stoma Educational Material
Description: It is an educational material made of rubber, similar to a stoma, that can be placed on the patient.
Study NCT05074147 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Reduction in the duration of antibiotic therapy 3 weeks or 6 weeks
Description: Drugs :~* Rifampin (IP an PO) : 10mg/Kg/12h~* Ofloxacin (PO) : 200Mg/8h~* Levofloxacin (PO) : 500mg ot 1g/ twice a day~* Ciprofloxacin : IV : 400mg/8h if Pseud spp ; 400mg/12h for others Gram-negative bacilli strains; PO : 1gr/12h if Pseud spp ; 750mg/12h for others Gram-negative bacilli strains~* Clindamycin : 600-900mg/8h~* Fusidic Acid : 500mg/8h~* Teicoplanin : 10mg/kg/12h for 5 dosis in combination, then in monotherapy.~* Ceftasidim : 2g/8h if Pseud spp ; 2g/12h for others Gram-negative bacilli strains~* Trimethoprim-sulfamethoxazole (800mg/160mg) : once per day if patient \< 80Kg ; one and a half per day if patient > 80Kg.~* Doxycyclin : 200mg/day~* Minocyclin : 100mg/8h to 12h~* Ceftriaxon : 1g to 2g/day in IV, IM or SC~* Cefotaxim : 1g to 2g/day in IV~* Pristinamycin : 1g thrice a day
Study NCT05019053 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Coping Crew
Description: Coping Crew consists of five 60-minute virtual intervention sessions coinciding with five weeks of EMI. Participants will receive psychoeducation, challenge cognitive biases or mythbust, and participate in behavioral exposure and behavioral experiments. An EMI component of this treatment will be included for the purpose of treatment monitoring and homework tracking. Participation in this EMI component involves the daily report of levels of anxiety, depression, stress, and loneliness. When participants endorse elevated levels on any of these constructs, they will receive a targeted message reminding them of the topics covered in COPING CREW. One month after the intervention session, COPING CREW participants will complete follow-up questionnaires and interview. Participants will also participate in a feedback session 3 months after the intervention.
Study NCT05703776 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nordic Walking
Description: Nordic Walking (NW) is an aerobic physical activity where regular walking is enhanced by the addition of the active use of specifically designed NW poles. The physical strain is distributed in a balanced way to various muscle groups of the whole body.
Study NCT06103682 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ablative local therapy
Description: Stereotactic ablative radiotherapy (SABR) or interventional radiology (IR) ablation therapy
Study NCT04869930 — intervention group
Intervention type: OTHER
Intervention: specimen collection
Description: participants will submit at minimum two of four required samples: fecal, urine, finger/toe-prick blood, and cheek swab, collected at home via commercially available kits
Study NCT06025461 — intervention group
Intervention type: OTHER
Intervention: no intervention
Description: no intervention
Study NCT05713370 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: high fat meal
Description: A high fat meal (milkshake) will be administered on the morning after the intervention of no exercise and no SR the night before.
Study NCT05713370 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: high fat meal
Description: A high fat meal (milkshake) will be administered on the morning after the intervention of no exercise and no SR the night before.
Study NCT04100187 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Anti-CD19-CAR
Description: Cells extracted, followed by induction chemotherapy before CD19-CAR infusion (dose escalation.)